Epstein-Barr Virus-Positive Lymphomas Exploit Ectonucleotidase Activity To Limit Immune Responses and Prevent Cell Death
Year: 2023
Type: article
Abstract: EBV is a ubiquitous pathogen responsible for significant global lymphoma burden, including Hodgkin lymphoma, numerous non-Hodgkin B, T, and NK cell lymphomas, and lymphoproliferative disorders. EBV is also associated with epithelial cancers and autoimmune diseases, such as multiple sclerosis.
Source: mBio
Authors: Philip T. Lange, Blossom Damania
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,900
Funders: Lymphoma Research Foundation, National Institutes of Health, Center for AIDS Research, University of Washington, National Cancer Institute, National Institute of Allergy and Infectious Diseases, National Institute of Dental and Craniofacial Research, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Awards: G1343030804, Impact of HIV on the Tumor Microenvironment, G1855353300, Modulation of Innate Immunity by KSHV, G7366156696, G9000033364, G9000157298, Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma, Viral Oncogenesis, Latency, and Replication, The University of North Carolina Center for AIDS Research, Cancer Center Support Grant, G958207224
OpenAlex ID: W4320709285